Genovique Specialties Corporation

Genovique Specialties Corporation was a United States-based specialty chemicals company established in 2005 by Arsenal Capital Partners. The company was formed from the Velsicol Chemical business unit and operated as a focused producer of chemical intermediates and specialty additives rather than as a broad, diversified chemical conglomerate. Its principal product portfolio included benzoic acid, sodium benzoate, and specialty plasticizers. The company was headquartered in Rosemont, Illinois, and maintained an international manufacturing and operating footprint. Its sites included a facility in Chestertown, Maryland, a site in Kohtla-Järve, Estonia, and a joint venture in Wuhan, China. This network gave Genovique a presence across North America, Europe, and Asia and supported its role in supplying industrial and specialty-chemical customers. Benzoic acid and sodium benzoate were central to the company's product identity. These materials are used in a range of industrial and commercial applications, including preservatives, intermediates, and formulation systems, although the available reference material does not specify individual customer markets or detailed end-use breakdowns. Specialty plasticizers formed another important part of the business, placing Genovique within the value-added additives segment of the chemicals industry. Genovique remained an independent company for approximately five years. In 2010, Eastman Chemical Company purchased Genovique Specialties. The transaction ended Genovique's independent corporate identity and brought its activities and product capabilities into Eastman's broader chemicals portfolio. Publicly available reference material does not provide a separate account of the acquisition price, transaction structure, post-acquisition brand treatment, or the subsequent disposition of individual facilities. Accordingly, Genovique is best described as a former specialty-chemicals company whose business was absorbed into Eastman after the 2010 acquisition.

Genovique Specialties Corporation was created in 2005 by Arsenal Capital Partners from the Velsicol Chemical business unit. Its formation represented the separation and establishment of a focused specialty-chemicals enterprise built around products that had previously been associated with Velsicol's operations. Rather than retaining the scope of a larger chemical group, Genovique concentrated on selected chemical products, including benzoic acid, sodium benzoate, and specialty plasticizers. The company was based in Rosemont, Illinois. Its manufacturing and operating sites extended beyond the United States, with facilities identified in Chestertown, Maryland, and Kohtla-Järve, Estonia. Genovique also participated in a joint venture located in Wuhan, China. The combination of these sites provided the company with production and commercial reach in North America, Europe, and Asia, although the available reference material does not identify the precise ownership percentages, capacities, customer list, or sales by region. Genovique's product mix placed it in the specialty and basic chemicals sector. Benzoic acid served as a core chemical product, while sodium benzoate represented a related derivative with applications in preservation and industrial formulations. Specialty plasticizers expanded the portfolio into performance additives used to modify the properties of manufactured materials. The source material confirms these product categories but does not provide sufficiently detailed information to attribute specific branded grades, technical specifications, or end markets. In 2010, Eastman Chemical Company acquired Genovique Specialties Corporation. The acquisition marked the end of Genovique's period as an independent company and transferred its business to a much larger chemical producer. Available references do not state the purchase price or give a detailed account of the integration process. They also do not establish whether the Genovique name continued as a distinct commercial brand after the transaction. The company is therefore generally treated as a former independent specialty-chemicals business whose operations became part of Eastman's portfolio.

1. 2010Acquisition by Eastman Chemical Company

   Eastman Chemical Company purchased Genovique Specialties, ending the company's independent corporate existence and adding its specialty-chemicals activities to Eastman's business.

   Source
2. 2005Genovique Specialties is formed

   Arsenal Capital Partners formed Genovique Specialties Corporation from the Velsicol Chemical business unit, establishing an independent specialty-chemicals company.

   Source

A focused specialty-chemicals supplier producing benzoic-acid derivatives and plasticizer products for industrial and formulation applications.

• Benzoic acidBasic and specialty chemicals

  Benzoic acid was one of Genovique's principal chemical products. It is an industrial chemical used directly in formulations and as an intermediate for other products. The available reference identifies it as part of Genovique's manufacturing portfolio but does not specify the company's individual grades, capacities, customers, or detailed end-use applications.

• Sodium benzoateChemical preservatives and industrial chemicals

  Sodium benzoate was a core Genovique product and a derivative of benzoic acid. It is commonly used in preservation and formulation applications, although the supplied source does not identify specific markets served by Genovique or provide product-level commercial details. The product was part of the business acquired by Eastman in 2010.

• Specialty plasticizersSpecialty additives

  Genovique manufactured specialty plasticizers, additives used to alter the flexibility, processing behavior, or performance of polymeric materials. This product area complemented the company's benzoic-acid chemistry and positioned it in higher-value industrial chemicals. The available material does not identify particular plasticizer chemistries, trade names, applications, or individual product launch dates.

• 2010Sale to Eastman Chemical CompanyM&A

  After operating as an independent specialty-chemicals company for about five years, Genovique became the subject of an acquisition by Eastman Chemical Company.

  What changed. Eastman Chemical Company purchased Genovique Specialties Corporation.

  Aftermath. The transaction ended Genovique's independent corporate status and incorporated its business into Eastman's chemicals portfolio. The purchase price and detailed integration outcomes are not identified in the available reference.

  Source
• 2005Creation of a focused specialty-chemicals companyStrategy

  Arsenal Capital Partners established Genovique from the Velsicol Chemical business unit, separating a defined portfolio of chemical products into a standalone company.

  What changed. The new company concentrated on benzoic acid, sodium benzoate, specialty plasticizers, and related operations.

  Aftermath. Genovique operated independently with sites in the United States and Estonia and a joint venture in China until its acquisition by Eastman in 2010.

  Source

• 2010Eastman Chemical Company acquires Genovique Specialties

  Eastman Chemical Company purchased Genovique Specialties Corporation, bringing the privately held specialty-chemicals business formed from Velsicol Chemical's former business unit into Eastman's operations.

  M&A
  Source

1. Genovique Specialties Corporation